drugset / Trial / NCT03321318
AK-R215 Pharmacokinetic Study Phase I
RandomizedCrossoverOpen-labelTreatment
Summary
An open label, randomized, 2-sequence, 2-period, single-dose cross-over study to evaluate the pharmacokinetics characteristics of AK-R215
Timeline
- Start
- 2017-07-13
- Primary completion
- 2017-09-18
- Completion
- 2018-01-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AK-R215 | Unknown | — | — |
| Subject | Bazedoxifene | Other / unclassified | 20 mg | — |
| Subject | Cholecalciferol | Other / unclassified | 800 iu | — |
Indications
No indication recorded.